Balaji Amines Limited · NSE:BALAMINES

Balaji Amines — Q2 FY25 Earnings Presentation

47 slides from Balaji Amines's earnings presentation, Nov 19, 2024

  1. Slide 1: Stock exchange intimation letter on Q2FY25 investor presentation

    19th November, 2024 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Ban

  2. Slide 2: Investor Presentation – November 2024

    Investor Presentation – November 2024

  3. Slide 3: Disclaimer

    Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti

  4. Slide 4: Results Highlights

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  5. Slide 5: Q2FY25: Financial Highlights

    Q2FY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -8% 15% 14% 387 393 74 46 19% 20% 356 70 41 61 36 16% 12% 11% 9% Q2FY24 Q1FY25 Q2FY25 Q2FY24 Q1FY25 Q2FY25 Q2FY24 Q1FY25 Q2FY25 Q2FY24 Q1FY25 Q2FY25 Revenue (Rs. Crore) EBITDA (Rs. C

  6. Slide 6: H1FY25: Financial Highlights

    H1FY25 : Financial Highlights Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Margin Consolidated -16% -13% -12% 857 164 104 19% 19% 749 144 87 12% 12% H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY25 H1FY24 H1FY25 Revenue (Rs. Crore) EBITDA (Rs. Crore) PAT (Rs. Crore) EBITDA & PAT Marg

  7. Slide 7: Q2FY25 - Consolidated Performance Highlights

    Q2FY25 - Consolidated Performance Highlights Revenue from Operations for Q2FY25 stood at ₹ 356 crore, as compared to ₹ 393 crore in Q1FY25. Total volumes stood at 26,348 MT for Q2FY25 as against 28,071 MT in Q1FY25. For Q2FY25, • Amines volumes stood at 7,616 MT • Amines Derivatives volumes stood at

  8. Slide 8: Q2FY25 - Consolidated Performance Highlights

    Q2FY25 - Consolidated Performance Highlights • N-Methyl Morpholine (NMM): The NMM plant with a capacity of 15 MT/Day is under execution at Unit IV. The detailed engineering is in the final stage and 50% of the equipment ordered. The civil works are likely to start before the end of Nov 2024. The pla

  9. Slide 9: Phase-2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV)

    Phase -2 & 3 Expansion Plans at our 90-acre Greenfield Project (Unit IV) EXECUTED ON SCHEDULE EXECUTED ON SCHEDULE IN PROGRESS n-Butylamine Methylamines Dimethyl Ether • We have undertaken capex for a new product, • Market Leader in Methylamines production in • Dimethyl Ether (DME) with a Capacity o

  10. Slide 10: Standalone Statement of Profit & Loss

    Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q2FY25 Q1FY25 Q-o-Q H1FY25 H1FY24 Y-o-Y Total Revenue 326 338 -3% 664 672 -1% Raw Material 176 187 363 396 Employee expense 18 17 35 32 Other expenses 68 70 138 135 EBITDA 64 64 0% 128 109 18% EBITDA Margin 20% 19% 19% 16% Depreciation

  11. Slide 11: Consolidated Statement of Profit & Loss

    Consolidated Statement of Profit & Loss Particulars (in Rs. Crore) Q2FY25 Q1FY25 Q-o-Q H1FY25 H1FY24 Y-o-Y Total Revenue 356 393 -9% 749 857 -30% Raw Material 188 217 405 478 Employee expense 19 19 38 37 Other expenses 79 82 161 177 EBITDA 70 74 -6% 144 164 -43% EBITDA Margin 20% 19% 19% 19% Depreci

  12. Slide 12: Standalone Balance Sheet Statement

    Standalone Balance Sheet Statement ASSETS (in Rs. Crore) Sep-24 Mar-24 EQUITY AND LIABILITIES (in Rs. Crore) Sep-24 Mar-24 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 715 719 (a) Equity Share capital 6 6 (b) Capital work-in-progress 214 141 (b) Other equity 1,573 1,528 (c) Intangib

  13. Slide 13: Consolidated Balance Sheet Statement

    Consolidated Balance Sheet Statement ASSETS (in Rs. Crore) Sep-24 Mar-24 EQUITY AND LIABILITIES (in Rs. Crore) Sep-24 Mar-24 (1) NON-CURRENT ASSETS EQUITY (a) Property, plant & equipment 882 891 (a) Equity Share capital 6 6 (b) Capital work-in-progress 283 203 (b) Other equity 1,764 1,716 (c) Intang

  14. Slide 14: Standalone Cash Flow Statement

    Standalone Cash Flow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Sep-24 Sep-23 Profit before Tax 109 91 Adjustment for Non-Operating Items 14 11 Operating Profit before Working Capital Changes 123 102 Changes in Working Capital -1 -99 Cash Generated from Operations 122 3 Les

  15. Slide 15: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Cash Flow Statement for twelve months ended (in Rs. Crore) Sep-24 Sep-23 Profit before Tax 118 138 Adjustment for Non-Operating Items 16 16 Operating Profit before Working Capital Changes 134 154 Changes in Working Capital 82 -69 Cash Generated from Operations 216 85

  16. Slide 16: About Us

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  17. Slide 17: Amines Industry – Unique but Critical Industry with growth potential

    Amines Industry – Unique but Critical Industry with growth potential The size of Aliphatic Amines industry globally The consumable nature of demand and the is $4.9 billion. Globally, the Amine industry is oligopolistic nature of the industry, results in oligopolistic with two-three producers a stron

  18. Slide 18: Balaji Amines Ltd – A Leading player in Aliphatic Amines in India

    Balaji Amines Ltd – A Leading player in Aliphatic Amines in India State-of-the-art Forward integrated manufacturing suite of products Largest manufacturer of Aliphatic Amines in facilities fully equipped with latest DCS 40+ Product Downstream products added based on strength of amine manufacturing w

  19. Slide 19: Our Products are supplied to India’s fast-growing Industries

    Our Products are supplied to India’s fast-growing Industries Industry Wise - Revenue Breakup 3% 4% 3% 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others 18

  20. Slide 20: Highly Experienced Management Team

    Highly Experienced Management Team Mr. A. Prathap Reddy Mr. D. Ram Reddy Mr. N. Rajeshwar Reddy Mr. A. Srinivas Reddy Executive Chairman Managing Director Whole Time Director Whole Time Director & CFO • 37 years of experience across • Civil Engineer by Education. various businesses. • B. Com. Over 4

  21. Slide 21: Diversified Product Portfolio

    Diversified Product Portfolio Particulars Amines Amine Derivatives Specialty & Other Chemicals • Aliphatic Amines find increasing • Amine Derivatives are used to make further consumption and applications in a salts and other complex chemical Intermediates and API’s • Albeit a small and fast growing

  22. Slide 22: Clientele

    Clientele Amines Amine Derivatives Specialty & Other Chemicals 21

  23. Slide 23: Well positioned Business Model aimed at Sustainable growth

    Well positioned Business Model aimed at Sustainable growth Focus towards high-value derivatives and Develop new indigenous technology for specialty chemicals with an aim to move up manufacturing products leading to lowering in the value-chain with vertical integration manufacturing costs & improving

  24. Slide 24: Key Products (Current & Proposed) in Portfolio

    Key Products (Current & Proposed) in Portfolio Product Existing Installed Capacity Proposed Capacity Application Areas (TPA) (TPA) Methyl Amine 88,000 - Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - Pharma, Agro, Dye & Rubber DMAHCL / DMAC 31,000 7,500 Pharma Choline Chloride 60% (Corn Cob) 6,000

  25. Slide 25: We are Global suppliers – a significant validation of our Capabilities

    We are Global suppliers – a significant validation of our Capabilities • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatem

  26. Slide 26: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities ISO Certificate Two Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP 02.05.2023 ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP

  27. Slide 27: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities Product Innovator of Distinguished Excellent CSR in Water Mahatma Award for “Company of the Year” in International Tourism & the Year in Chemicals Contribution in the Conservation Sustainable and Responsible Chemicals at FICCI Chemicals Hospita

  28. Slide 28: We are Growing…Sustainably and Consistently

    We are Growing…Sustainably and Consistently India Ratings Affirms Balaji Amines’ Bank Facilities at ‘IND AA’ “Latest Rating is Non- fund based Facilities INR 1500 Million IND A1+ ; Fund Based Working Capital Facilities INR 1450 Million IND AA / Stable / IND A1+ • Largest manufacturer of aliphatic am

  29. Slide 29: High entry barrier Business – Paving way for Sustainable growth

    High entry barrier Business – Paving way for Sustainable growth Complex manufacturing process Niche product offering with high High fixed costs, with fixed asset requiring high levels of lead time in customer approvals turns hovering in the range of 1.5- technological know-how. Efficient 2x. Optimum

  30. Slide 30: Well positioned Business Model aimed at Sustainable growth

    Well positioned Business Model aimed at Sustainable growth Value-Added Products Applicability in Solvents segment Capex towards high-value derivatives and specialty chemicals will materialize into higher 01 Solvents account for 80%-90% of the mass utilised in a typical pharmaceutical chemical 05 rev

  31. Slide 31: Greenfield Project to fuel growth and add Revenue Visibility

    Greenfield Project to fuel growth and add Revenue Visibility Strategically Project Accorded Product Profile Balaji Specialty Located Plant Mega Project Status Chemicals Environmental In Phase-1 of Greenfield Electronic Grade DMC Maharashtra’s Energy and clearance received Project Ethylamines Electro

  32. Slide 32: Greenfield Project to fuel growth and add Revenue Visibility

    Greenfield Project to fuel growth and add Revenue Visibility New Products = First High Demand for Hotel Expansion Solar Power Plant Mover advantage Products Significant The demand of Planning to add 40 The 20 MW Greenfield Solar opportunity exists Methylamines has new rooms which Power Plant is prog

  33. Slide 33: About Balaji Speciality Chemicals

    About Balaji Speciality Chemicals Balaji Speciality Chemicals Limited (BSCL) is Manufacturing 01 products such as Ethylene Diamine (EDA), Piperazine Anhydrous 04 (PIP) , Di Ethylene Tri Amine (DETA), Amino Ethyl Ethanol Amines BAL owns 55% in subsidiary Balaji Speciality Chemicals Pvt. Ltd (AEEA) an

  34. Slide 34: R&D led Investments to provide significant early mover advantage

    R&D led Investments to provide significant early mover advantage New Products Optimization Integration Continuous efforts to optimize Backward and forward Identification of new products utilization of energy, utilities & integration of products to and development of latest raw materials consumption

  35. Slide 35: Hotel Division

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  36. Slide 36: Balaji Sarovar Premiere – Best in class Business Hotel in Solapur

    Balaji Sarovar Premiere – Best in class Business Hotel in Solapur • Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur • Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity • Tied up with Sarovar Group for the Management of the Ho

  37. Slide 37: Balaji Sarovar Premiere – H1FY25 Operating Matrix

    Balaji Sarovar Premiere – H1FY25 Operating Matrix Constitutes 129 Rooms 2.14% of Negligible Routine Capex incurred Rs. 4,820 ARR Total Revenue 67% Rs. 3,221 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ARR : Average Room Revenue RevPAR: Revenue per Available Room 36

  38. Slide 38: Financial Performance

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  39. Slide 39: Consolidated Performance Highlights

    Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 379 353 244 232 941 186 97 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 2020 2021 2022 2023 2024 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31.8%

  40. Slide 40: Strong Core ROCE Profile

    Strong Core ROCE Profile Particulars (Rs. Crs.) FY23 FY24 Consolidated Debt 58 20 ▪ For FY23, investments made to the tune of Rs. 95.87 crore for Unit 4’s n-Butylamine plant and Methylamine plant and Unit 3’s power Consolidated Networth 1698 1893 plant is not considered, as the operations are work i

  41. Slide 41: Consistent Dividend Payout

    Consistent Dividend Payout 550% 500% 300% 200% 140% 160% FY19 FY20 FY21 FY22 FY23 FY24 Particulars (Rs. per share) FY19 FY20 FY21 FY22 FY23 FY24 Consolidated Book Value 183 206 281 406 524 584 Consolidated EPS 36 32 74 114 100 63 Dividend 2.80 3.20 4.00 6.00 10.00 11.00 40

  42. Slide 42: Moving towards Growth Prospects

    Results Highlights About Us Hotel Division Financial Performance Moving towards Growth Prospects

  43. Slide 43: Balaji Amines Ltd - Progressing steadily

    Balaji Amines Ltd - Progressing steadily Unit 4: Increased capacity Unit 4 : Improvements at Improvements at utilization & capacity Greenfield Capex Phase - 2 & 3 Subsidiary Plant Subsidiary Plant additions of Phase - 1 capex Investments to be made in various Capex for Phase 2 & 3 of Higher capacity

  44. Slide 44: ESG & CSR Initiatives

    ESG & CSR Initiatives Distributed Sanitary Balak Palak Activity Napkin Incinerator Book Distribution and Vending Machine dt. 17.02.2024 at Saraswati High School, Tamalwadi and Z.P. School, Ghandora dt. 29.02.2024 Constructed SSC Board Exam classroom at Z. P. Books Primary School, Distribution for Go

  45. Slide 45: ESG & CSR Initiatives

    ESG & CSR Initiatives Constructed Toilet Contstruction of Block at Shree Toilet Block at Z.P. Basaveshwar School, Jalkot dt. Prashala, Kazikanbas 16.01.2024 dt 31.01.2024. Constructed kitchen shed at Constructed Muk Badhir classrooms at Niwasi Shala, Saraswati Mohol dt. Vidyalay, 03.01.2024 Tamalwad

  46. Slide 46: ESG & CSR Initiatives

    ESG & CSR Initiatives Contructed Boys Distibuted school and Ladies Hostels benches to Shakti at Government Primary Ashram Polytechnic College, School, Mulegaon, Nizambad dt. Solapur dt. 09.08.2023 25.08.2023 Donated 1000 trees for plantation under Maza Gav Maza Vatvruksh programme dt 14.06.2023 45

  47. Slide 47: Thank You

    For further information, please contact: Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 Email - cs@balajiamines.com www.balajiamines.com Investor Relations Advisors : Orient Capital (a division of Link Group) Mr. Bhavya Shah +91 8082748577 bhavya.shah@linkintime.co.in Mr. Hitesh Agrawal +9

Balaji Amines — Q2 FY25 Earnings Presentation on 6ix